Pharmaceuticals, Biotechnology and Life Sciences
Recipharm, a global contract development and manufacturing organisation (CDMO), has announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater for customers’ vaccine products at clinical and commercial scales, in both freeze-dried and liquid forms.
Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new director of business management for the USA and Canada, the company said in a press release on Tuesday.
Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare…